MARC record from Internet Archive

LEADER: 03359cam 2200553 a 4500
001 ocm41297920
003 OCoLC
005 20201126185650.0
008 990504s1999 enka b 001 0 eng d
040 $aEMM$beng$cNLM$dEMM$dNRM$dVAM$dBAKER$dYDXCP$dCGC$dAU@$dEYM$dOCLCF$dOCLCQ$dOCLCO$dCNUTO$dPAU$dUWO$dOCLCQ$dOCLCO
016 7 $a100891973$2DNLM
019 $a1173840762$a1191391618
020 $a9781853175916
020 $a1853175919
035 $a(OCoLC)41297920$z(OCoLC)1173840762$z(OCoLC)1191391618
042 $anlmcopyc
050 14 $aRC685.H8$bB34 1999
060 00 $a1999 E-574
060 10 $aWG 340$bB415h 1999
080 $a616.12-008.331.1
082 04 $a616.132$221
084 $aJ1c6a$qUkBrU-I$2cmedlit
100 1 $aBeevers, D. G.$q(D. Gareth)
245 10 $aHypertension in practice /$cD. Gareth Beevers, Graham A. MacGregor.
250 $a3rd ed.
260 $aLondon :$bMartin Dunitz ;$aMalden, MA :$bDistributed in the United States by Blackwell Science,$c1999.
300 $a286 pages :$billustrations (some color) ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aCh. 1. The importance of hypertension -- Ch. 2. Hypertension and cardiovascular risk -- Ch. 3. The causes of hypertension: epidemiological clues -- Ch. 4. Factors controlling blood pressure -- Ch. 5. Drug-induced hypertension -- Ch. 6. Blood pressure measurement -- Ch. 7. The assessment of a new patient -- Ch. 8. Further investigation of hypertension -- Ch. 9. The benefits of antihypertensive treatment -- Ch. 10. Non-drug control of blood pressure.
505 0 $aCh. 11. A review of antihypertensive drugs -- Ch. 12. Schemes for reducing blood pressure -- Ch. 13. Hypertension in primary medical care -- Ch. 14. Hypertension with other diseases -- Ch. 15. Hypertension in the elderly -- Ch. 16. Hypertension in pregnancy -- Ch. 17. Blood pressure in children.
520 1 $a"The need for a third edition so soon after the second was because of the publication of three important long-term outcome studies in 1997 and 1998. These were the European systolic hypertension trial (SYST-EUR), the Hypertension Optimal Treatment (HOT) trial and the UK Prospective Diabetes Study (UKPDS). These provide a great deal of new information on the correct management of hypertension. In addition there have been controversies on the use of calcium channel blockers and the striking success of the many angiotensin receptor antagonists. All these developments are reviewed in detail and appropriate clinical recommendations are provided."--BOOK JACKET.
650 0 $aHypertension.
650 7 $aHypertension.$2fast$0(OCoLC)fst00965831
650 12 $aHypertension.
650 22 $aAntihypertensive Agents.
700 1 $aMacGregor, Graham.
856 42 $3The Sabin W. Colton, Jr., Memorial Fund Home Page$uhttp://hdl.library.upenn.edu/1017.12/366306
938 $aBaker & Taylor$bBKTY$c139.95$d139.95$i1853175919$n0003224565$sactive
938 $aYBP Library Services$bYANK$n100112458
029 0 $aNLM$b100891973
029 1 $aAU@$b000023476779
029 1 $aAU@$b000026732042
029 1 $aNZ1$b11768310
029 1 $aYDXCP$b100112458
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 82 OTHER HOLDINGS